. Lecanemab: European drug agency upholds decision to recommend Alzheimer's drug. BMJ. 2025 Mar 3;388:r439. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.